Innovating.works Conecta tu I+D

Mostrando 1 al 20 de 72 resultados

INTERACT: Interdisciplinary Marie Sk odowska Curie Action for Health NOVO NORDISK AS participó en un HORIZON EUROPE: HORIZON-MSCA-2023-COFUND-01 The last decades are characterised by great breakthroughs in the understanding, diagnosing, and treating of many diseases. As fields advance...
2024-09-13 - 2030-08-31 | Financiado

SYNTHIA: Synthetic Data Generation Framework for Integrated Validation of Use Cases and AI Healthcare Applica... SYNTHIA is an ambitious collaboration between public and private institutions to facilitate the responsible use of Synthetic Data (SD) in he...
2024-08-09 - 2029-08-31 | Financiado

VICT3R: Developing and implementing VIrtual Control groups To reducE animal use in toxicology Research VICT3R, a public-private partnership running under the European Innovative Health Initiative, aims to significantly reduce the number of ani...
2024-07-26 - 2028-02-29 | Financiado

MC4DD: Macrocycles for Drug Discovery Better drugs are one of the most efficient and sustainable ways to improve health care, a key strategic orientation in Horizon Europe. New d...
2024-07-10 - 2028-10-31 | Financiado

AIPD: AI in Parkinson s Disease In response to the growing need for specialized data scientists in healthcare, our initiative aims to establish an international, interdisci...
2024-07-08 - 2028-10-31 | Financiado

Cilia-AI: European Training Program for Deconvolution of Multi scale Cilia Function in Health and Disease by I... NOVO NORDISK AS participó en un HORIZON EUROPE: HORIZON-MSCA-2023-DN-01 Cilia-AI will train a new generation of multidisciplinary biomedical researchers and entrepreneurs, and those specializing in emerging machi...
2024-06-25 - 2028-12-31 | Financiado

LIVERAIM: A Biomarker Based Platform for Early Diagnosis of Chronic Liver Disease to Enable Personalized Thera... NOVO NORDISK AS participó en un HORIZON EUROPE: HORIZON-JU-IHI-2022-03-single-stage Liver cirrhosis and liver cancer are common and responsible for high morbidity, impaired quality of life, major costs for healthcare systems...
2023-11-27 - 2030-02-28 | Financiado

PREDICTOM: PREDICTION OF ALZHEIMER S DISEASE USING AN AI DRIVEN SCREENING PLATFORM NOVO NORDISK AS participó en un HORIZON EUROPE: HORIZON-JU-IHI-2022-03-single-stage Alzheimer’s disease (AD) and related disorders leading to dementia are associated with staggering costs and suffering. Recently, there has b...
2023-10-30 - 2027-10-31 | Financiado

COMBINE-CT: Combining CT diagnostic data and interventional approaches for futureproof cardiology care NOVO NORDISK AS participó en un HORIZON EUROPE: HORIZON-JU-IHI-2022-03-single-stage "Coronary artery disease (CAD) is caused by the pathological process in which fat, cholesterol and calcium accumulate on the arterial wall....
2023-10-27 - 2027-10-31 | Financiado

SCREEN4CARE: Shortening the path to rare disease diagnosis by using newborn genetic screening and digital technol... NOVO NORDISK AS participó en un H2020: H2020-JTI-IMI2-2020-23-two-stage In the EU alone, according to the Orphanet DB (https://pubmed.ncbi.nlm.nih.gov/31527858/), 30 million persons, 3,5-6% of the general populat...
2021-10-13 - 2026-09-30 | Financiado

BEAMER: BEhavioral and Adherence Model for improving quality health outcomes and cost Effectiveness of heal... NOVO NORDISK AS participó en un H2020: H2020-JTI-IMI2-2020-23-two-stage The main objective of the Project is to create BEAMER, a disease-agnostic behavioral and adherence model for improving quality, health outco...
2021-09-27 - 2026-08-31 | Financiado

BIGPICTURE: Central Repository for Digital Pathology NOVO NORDISK AS participó en un H2020: H2020-JTI-IMI2-2019-18-two-stage BIGPICTURE, a pathology-led consortium, has the vision to become the catalyst in digital transformation in Pathology. Our mission is to crea...
2020-11-26 - 2027-01-31 | Financiado

ARDAT: Accelerating Research Development for Advanced Therapies NOVO NORDISK AS participó en un H2020: H2020-JTI-IMI2-2019-18-two-stage Major current hurdles for wide clinical use of AAV vectors are attributable primarily to: (i) host elimination by both immune and non-immune...
2020-11-11 - 2025-10-31 | Financiado

SIMPPER_MedDev: Surface Integrity for Micro Nano Processing of Polymers A European Research Training Network for Hi... NOVO NORDISK AS participó en un H2020: H2020-MSCA-ITN-2020 Increased demand for high-quality healthcare for our aging population means that medical device design must satisfy multiple requirements fo...
2020-08-17 - 2025-10-31 | Financiado

SOPHIA: Stratification of Obesity Phenotypes to Optimize Future Therapy NOVO NORDISK AS participó en un H2020: H2020-JTI-IMI2-2019-17-two-stage SOPHIA will optimise the future treatment of obesity. The challenge is that clinicians, payers and patients view obesity as a failure of sel...
2020-05-26 - 2025-05-31 | Financiado

INNODIA HARVEST: Translational approaches to disease modifying therapy of type 1 diabetes HARVESTing the fruits of... NOVO NORDISK AS participó en un H2020: H2020-JTI-IMI2-2019-19-single-stage Building on the strong foundations of INNODIA, with its unique, Europe-wide clinical and basic research network for the study of type 1 diab...
2020-04-16 - 2024-04-30 | Financiado

PharmaLedger: PharmaLedger NOVO NORDISK AS participó en un H2020: H2020-JTI-IMI2-2018-15-two-stage The PharmaLedger project will create a blockchain-based framework for the efficient digitization of the healthcare industry. The goal of the...
2019-12-16 - 2022-12-31 | Financiado

NSC-Reconstruct: Novel Strategies for Cell based Neural Reconstruction NOVO NORDISK AS participó en un H2020: H2020-SC1-BHC-2018-2020 Neurodegenerative diseases and brain injuries affect large patient groups and carry large unmet clinical needs. NSC-Reconstruct will respond...
2019-12-11 - 2024-12-31 | Financiado

EU-PEARL: EU Patient cEntric clinicAl tRial pLatform NOVO NORDISK AS participó en un H2020: H2020-JTI-IMI2-2018-15-two-stage EU-PEARL has the ambition of transforming the current approach of conducting single-compound clinical trials into the use of cross-company I...
2019-11-27 - 2023-04-30 | Financiado

ConcePTION: Building an ecosystem for better monitoring and communicating of medication safety in pregnancy and... NOVO NORDISK AS participó en un H2020: H2020-JTI-IMI2-2017-13-two-stage ConcePTION partners have united around a shared vision that we have a societal obligation to radically and rapidly reduce uncertainty about...
2019-05-06 - 2024-12-31 | Financiado

Novo Nordisk